ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an ...
Good morning, and welcome to Bio-Techne's Earnings Conference Call for the Fourth Quarter and Fiscal Year 2025. [Operator Instructions] I would now like to turn the call over to David Clair, ...
The DCF model implemented in this article suggests that Bio-Techne is overvalued by 34.53%. Bio-Techne has allocated significant financial resources to capex. Due to these resources, its revenues ...
Fintel reports that on November 20, 2025, Argus Research maintained coverage of Bio-Techne (NasdaqGS:TECH) with a Buy recommendation. As of November 17, 2025, the average one-year price target for Bio ...
The Graduate Architecture, Urban Design, and Landscape Architecture programs (GA/LA/UD) at Pratt Institute are proud to participate in the Biodesign Challenge (BDC) with their project submission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback